These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9263168)

  • 21. How to predict prognosis in early rheumatoid arthritis.
    Morel J; Combe B
    Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):137-46. PubMed ID: 15588975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early rheumatoid arthritis.
    Mitchell KL; Pisetsky DS
    Curr Opin Rheumatol; 2007 May; 19(3):278-83. PubMed ID: 17414956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rheumatologic diagnostic serology: tests which test clinicians.
    Wong ML
    N Z Med J; 2004 Oct; 117(1203):U1095. PubMed ID: 15477919
    [No Abstract]   [Full Text] [Related]  

  • 24. The Nijmegen inception cohort of early rheumatoid arthritis.
    Welsing PM; van Riel PL
    J Rheumatol Suppl; 2004 Mar; 69():14-21. PubMed ID: 15053447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
    Lee AN; Beck CE; Hall M
    Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach.
    Tedesco A; D'Agostino D; Soriente I; Amato P; Piccoli R; Sabatini P
    Autoimmun Rev; 2009 Jan; 8(3):233-7. PubMed ID: 18708166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis.
    Jansen LM; van Schaardenburg D; van der Horst-Bruinsma I; van der Stadt RJ; de Koning MH; Dijkmans BA
    J Rheumatol; 2003 Aug; 30(8):1691-5. PubMed ID: 12913923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease.
    Orbach H; Gilburd B; Brickman CM; Gerli R; Shoenfeld Y
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):892-3. PubMed ID: 12455175
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prognosis markers and therapeutic approach in rheumatoid arthritis].
    Figueroa Pedrosa MM; González Beneitez C; Belzunegui Otano J
    Rev Clin Esp; 2000 May; 200 Monog 1():87-95. PubMed ID: 10901032
    [No Abstract]   [Full Text] [Related]  

  • 30. Extremity magnetic resonance imaging in rheumatoid arthritis: report of the American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force.
    American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force
    Arthritis Rheum; 2006 Apr; 54(4):1034-47. PubMed ID: 16572437
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-cyclic citrullinated peptide antibody in early rheumatoid arthritis: comment on the editorial by Scott.
    van Venrooij WJ; van de Putte LB; van den Hoogen FH
    Arthritis Rheum; 2003 Mar; 48(3):857; author reply 857-8. PubMed ID: 12632446
    [No Abstract]   [Full Text] [Related]  

  • 32. How does one assess early rheumatoid arthritis in daily clinical practice?
    van Riel PL; Schumacher HR
    Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):67-76. PubMed ID: 11358415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-CCP antibodies as an aid to prioritization of patients referred to the rheumatology clinic.
    Madan A; Belshaw R; Grennan D
    QJM; 2007 Nov; 100(11):737-8. PubMed ID: 17951317
    [No Abstract]   [Full Text] [Related]  

  • 35. Does early rheumatoid arthritis exist?
    Dixon WG; Symmons DP
    Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):37-53. PubMed ID: 15588970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Novel autoantibodies for the diagnosis of rheumatoid arthritis].
    Steiner G; Smolen JS
    Z Rheumatol; 2002 Dec; 61(6):667-73. PubMed ID: 12491130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort).
    Kirkham BW; Lassere MN; Edmonds JP; Juhasz KM; Bird PA; Lee CS; Shnier R; Portek IJ
    Arthritis Rheum; 2006 Apr; 54(4):1122-31. PubMed ID: 16572447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis.
    Kuriya B; Cheng CK; Chen HM; Bykerk VP
    Ann Rheum Dis; 2009 Sep; 68(9):1482-5. PubMed ID: 19015211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MBDA: what is it good for?
    Yazici Y; Swearingen CJ
    Ann Rheum Dis; 2014 Nov; 73(11):e72. PubMed ID: 25057179
    [No Abstract]   [Full Text] [Related]  

  • 40. [Can the outcome of rheumatoid arthritis be predicted at the onset of the disease?].
    Combe B
    Rev Rhum Ed Fr; 1994; 61(7-8):477-9. PubMed ID: 7833881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.